Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.

about

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial.Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.

P2860

Q48520500-39A055F0-476E-456F-81B0-72531E36E3B4 Q55456183-5C99E380-3250-42E5-956A-60D114423A39

P2860

Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q41248630

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Long-Term Extensions of Random ...... Moderate Alzheimer's Disease.

@en

type

Item

label

Long-Term Extensions of Random ...... Moderate Alzheimer's Disease.

@en

prefLabel

Long-Term Extensions of Random ...... Moderate Alzheimer's Disease.

@en

P1476

Long-Term Extensions of Random ...... Moderate Alzheimer's Disease.

@en

P2093

Ann Holstein

http://www.w3.org/2001/XMLSchema#string

Carl Sadowsky

http://www.w3.org/2001/XMLSchema#string

Enchi Liu

http://www.w3.org/2001/XMLSchema#string

Ghislaine Le Prince Leterme

http://www.w3.org/2001/XMLSchema#string

Hideo Suzuki

http://www.w3.org/2001/XMLSchema#string

J Michael Ryan

http://www.w3.org/2001/XMLSchema#string

Kevin Booth

http://www.w3.org/2001/XMLSchema#string

Michael Hull

http://www.w3.org/2001/XMLSchema#string

Nzeera Ketter

http://www.w3.org/2001/XMLSchema#string

Tamotsu Yoshiyama

http://www.w3.org/2001/XMLSchema#string

P2860

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's disease

A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease.

Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials.

Probabilistic Cost-Effectiveness Analysis of Vaccination for Mild or Moderate Alzheimer's Disease

Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis.

Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study.

Control of hypertension with medication: a comparative analysis of national surveys in 20 countries.

P304

696-708

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1567205014666170117101537

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heii Arai

P577

2017-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28124589

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5543567

http://www.w3.org/2001/XMLSchema#string

Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.

about

P2860

P2860

Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932